Autopsy report · NCT02532062
The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung Cancer
Cause of deathFunding or business
“lost funding, limited eligibility due to pre-existing vitamin D supplementation”
Life of this trial
- Registered 5 months before it started.
- Ran for about 2 years 5 months before it stopped.
- 10 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University of Pittsburgh
- Sponsor type
- University, hospital or other
- Conditions
- Deficiency of Vitamin D3; COPD
- Interventions
- Cholecalciferol; multivitamin; Placebo
- Participants
- 10
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Vitamin D to Prevent Severe Asthma Exacerbations (Vit-D-Kids Asthma)
“Futility of vitamin D supplementation based on protocol threshold: \<30% conditional power to detect pre-specified effect- 16% reduction in severe exacerbations.” - AIDI - Research & Development of a Multisensor-Based Machine Learning Technology for Real-Time Automated Detection of COVID-19 Decompensation
“No eligible patients could be found and funding was lost” - Effects of Neuro-Stim System on Pain, Sleep, and Opioid Use
“Lost funding from sponsor” - Brain Ion Homeostasis, Lithium and Bipolar Disorder
“Lost funding due to low enrollment” - A Randomized Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Effects of Alagebrium on Exercise in Subjects With Diastolic Heart Failure
“Sponsor lost funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.